In our preliminary study, we try to investigate the feasibility of SPECT/CT imaging of pancreatic cancer by targeting ITGA5 in PSCs using 125I-labeled ITGA5 inhibitor AV3 peptide as the imaging agent. The gene discussed is ITGA5; the disease is pancreatic neoplasm.